MedTrace Logo

Shiatsu for Chronic Non-Inflammatory Pain in Children and Adolescents

NCT06929598 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-09-04

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if adding Shiatsu therapy to standard treatment can improve quality of life in children and adolescents with chronic pain that is not caused by inflammation. The main question it aims to answer is: Does Shiatsu therapy help improve the quality of life in children with long-lasting pain?

All participants will continue their regular treatment and will also:

* Receive a 30-minute Shiatsu session once a week for six weeks
* Complete questionnaires about their quality of life and family impact before, during, and after the treatment period

The study includes about 40 participants between the ages of 10 and 18, who are already being followed at the pediatric pain and rheumatology clinics at Tel Aviv Sourasky Medical Center.

Conditions

  • Chronic Pain
  • Chronic Pain Syndrome
  • Chronic Pain and Comorbid Emotional Problems
  • Chronic Pain, Psychogenic
  • Chronic Pain, Widespread
  • Fibromyalgia
  • Fibromyalgia Syndrome
  • Functional Pain

Interventions

BEHAVIORAL

Shiatsu Therapy

Participants will receive one 30-minute session of Shiatsu therapy per week for 6 weeks. Therapy will be provided by trained Shiatsu practitioners under a standardized protocol developed for this study.

Sponsors & Collaborators

  • Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

    collaborator UNKNOWN

  • Dana-Dwek Children's Hospital

    collaborator UNKNOWN

  • Tel Aviv University

    lead OTHER

Principal Investigators

  • Merav Heshin-Bekenstein, MD · Dana Dwek Children's Hospital, Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
10 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-01
Primary Completion
2027-04-30
Completion
2027-04-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06929598 on ClinicalTrials.gov